These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37482688)

  • 1. Hypothermia During Intravenous Immunoglobulin Infusion in 2 Young Children.
    Assefa T; Norris M; Alperin RA; Simson GG; Glick AF
    Clin Pediatr (Phila); 2024 Jun; 63(6):733-737. PubMed ID: 37482688
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and Safety of Hospital-Based Intravenous Immunoglobulin and Home-Based Self-Administered Subcutaneous Immunoglobulin in Polish Children with Primary Immunodeficiency Diseases.
    Bal K; Kałuzińska-Parzyszek I; Sobocińska A; Podlecka D; Jerzyńska J; Stelmach I
    Indian J Pediatr; 2015 Aug; 82(8):768-9. PubMed ID: 25786586
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid intravenous immunoglobulin infusions in children with idiopathic thrombocytopenic purpura.
    Rajantie J; Mäkipernaa A; Lanning M
    Eur J Pediatr; 1994 Nov; 153(11):862. PubMed ID: 7843205
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immunoglobulin for neonates.
    Green A
    MCN Am J Matern Child Nurs; 1991; 16(4):208-11. PubMed ID: 1943529
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on.
    Bierling P; Godeau B
    Vox Sang; 2004 Jan; 86(1):8-14. PubMed ID: 14984554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons.
    Falsey AR; Koval C; DeVincenzo JP; Walsh EE
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28054734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of high-dose intravenous immunoglobulin on virus load in HIV-infected children.
    Church JA; Fox S; Gomperts E
    J Acquir Immune Defic Syndr; 1999 Nov; 22(3):309-11. PubMed ID: 10770354
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of hemolysis with high dose intravenous immunoglobulin therapy in pediatric patients: An open-label prospective trial.
    Akman AO; Kara FK; Koksal T; Cakir BC; Karagol C; Sayli T
    Transfus Apher Sci; 2017 Aug; 56(4):531-534. PubMed ID: 28818402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
    Barsheshet A; Marai I; Appel S; Zimlichman E
    Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin: prevention and treatment of disease. Summary of the NIH Consensus Development Conference.
    Transfus Med Rev; 1991 Jul; 5(3):171-2. PubMed ID: 1821178
    [No Abstract]   [Full Text] [Related]  

  • 11. [Guillain-Barré syndrome in children treated with intravenous immunoglobulin].
    Andersen UM
    Ugeskr Laeger; 1993 Oct; 155(42):3392-4. PubMed ID: 8259633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-losing enteropathy after the total cavopulmonary connection: impact of intravenous immunoglobulin.
    Zaupper LB; Nielsen BW; Herlin T
    Congenit Heart Dis; 2011; 6(6):624-9. PubMed ID: 22010984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of intravenous immunoglobulin treatment.
    Caress JB; Kennedy BL; Eickman KD
    Expert Opin Drug Saf; 2010 Nov; 9(6):971-9. PubMed ID: 20408737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aseptic meningitis: a frequent side-effect of intravenous immunoglobulin?
    Preminger-Shapiro R; Nussinovitch M; Soen G; Varsano I
    Eur J Pediatr; 1995 Oct; 154(10):866-7. PubMed ID: 8529693
    [No Abstract]   [Full Text] [Related]  

  • 15. Human intravenous immunoglobulin and its traceability.
    Nolan D; O'Connor MB; Lynch D; Breen K
    Ir Med J; 2009 May; 102(5):160-1. PubMed ID: 19623817
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease.
    Shrestha S; Wiener HW; Olson AK; Edberg JC; Bowles NE; Patel H; Portman MA
    J Allergy Clin Immunol; 2011 Sep; 128(3):677-80. PubMed ID: 21601260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiorgan failure induced by intravenous immunoglobulin.
    Ikeda M; Hamasaki Y; Hataya H; Honda M; Sugai K
    Acta Paediatr; 2000 Nov; 89(11):1393. PubMed ID: 11106058
    [No Abstract]   [Full Text] [Related]  

  • 18. Immediate infusion-related adverse reactions to intravenous immunoglobulin in a prospective cohort of 1765 infusions.
    Bichuetti-Silva DC; Furlan FP; Nobre FA; Pereira CT; Gonçalves TR; Gouveia-Pereira M; Rota R; Tavares L; Mazzucchelli JT; Costa-Carvalho BT
    Int Immunopharmacol; 2014 Dec; 23(2):442-6. PubMed ID: 25257732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics.
    Shapiro RS
    Pediatr Allergy Immunol; 2013 Feb; 24(1):49-53. PubMed ID: 23331529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience with the use of immune intravenous immunoglobulin in symptomatic children with human immunodeficiency virus infection].
    Jiménez E; Carrer MT; Pérez Dieppa I; Ortiz L; Fernández M
    Bol Asoc Med P R; 1991 Dec; 83(12):538-42. PubMed ID: 1811606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.